Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument

NCT05171127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2023-03-09

No results posted yet for this study

Summary

Differentiation between glioma tumor tissue and normal cerebral tissue using Diffuse Reflectance Spectroscopy (DRS) on surgical tissue samples ex-vivo

Conditions

Interventions

PROCEDURE

Diffuse Reflectance Spectroscopy

Measurements of DRS patterns in extirpated tumor and cerebral tissue

Sponsors & Collaborators

  • Philips Healthcare

    collaborator INDUSTRY
  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Oscar Persson, MD, PhD · Karolinska University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171127 on ClinicalTrials.gov